Energie rinnovabili ed emissioni di CO2 nei paesi del Mediterraneo

Autor: Silvana Bartoletto e Antonio Garofalo

Publikováno v: Rapporto sulle economie del Mediterraneo. Edizione 2029, edited by Salvatore Capasso, pp. 193–217. Bologna: Societa Editrice il Mulino, 2019
info:cnr-pdr/source/autori:Silvana Bartoletto e Antonio Garofalo/titolo:Energie rinnovabili ed emissioni di CO2 nei paesi del Mediterraneo/titolo_volume:Rapporto sulle economie del Mediterraneo. Edizione 2029/curatori_volume:Salvatore Capasso/editore: /anno:2019

Obiettivo del presente capitolo è quello di analizzare il ruolo delle energie rinnovabili nell'area Mediterranea1, evidenziando le differenze tra i paesi facenti parte dell'Unione europea e quelli appartenenti ad altre aree, come il Nord Africa e il

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::32249418c07f3753d31993bb85aaeaed
http://www.cnr.it/prodotto/i/426766

Cognition and behavior in children with benign epilepsy with centrotemporal spikes (BECTS)

Autor: Angela F. Caveney, S. Berent, J. L. Huffman, E. A. Garofalo, U. Sharma, B. Giordani, J. M. Giles, D. Laughrin

Publikováno v: Epilepsy Research. 70:89-94

Characteristics of cognitive deficits in benign childhood epilepsy with centrotemporal spikes (BECTS) remain unclear. The authors screened 200 BECTS children presenting for a clinical trial, finding relative weaknesses in fine motor control, visual l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c54f93aab9536f075377fd6d0a2171b
https://doi.org/10.1016/j.eplepsyres.2006.02.005

A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures

Autor: David Chadwick, M.W. Pierce, Martha Greiner, Henning Anhut, Jeannine Alexander, Guta Murray, E. A. Garofalo

Publikováno v: Neurology. 51:1282-1288

Background: Gabapentin is widely approved as add-on therapy for epilepsy treatment for partial seizures with and without secondary generalization. To investigate the efficacy of gabapentin administered as monotherapy in patients with newly diagnosed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f42cc3b216461a4e4f6590dfcd674b6e
https://doi.org/10.1212/wnl.51.5.1282

Gabapentin monotherapy: I. An 8-day, double-blind, dose controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures

Autor: J. G. Crockatt, D. B. Leiderman, M. J. Morrell, W. Rosenfeld, H. H. Morris, E. A. Garofalo, L. LaMoreaux, G. K. Bergey, Warren T. Blume, P. E. Penovich, M.W. Pierce

Publikováno v: Neurology. 49:739-745

We evaluated the efficacy and safety of gabapentin administered as monotherapy in an 8-day, randomized, double-blind, dose-controlled, parallel-group, multicenter study comparing dosages of 300 and 3,600 mg/d gabapentin in 82 hospitalized patients wh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7b02f093630633d6a371ec297e7007e9
https://doi.org/10.1212/wnl.49.3.739

Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures

Autor: Silke Messmer, Lloyd Knapp, Alan R. Kugler, E. A. Garofalo, Caroline M. Lee, Santiago Arroyo, Henning Anhut

Publikováno v: Epilepsia. 45(1)

Summary: Purpose: To evaluate pregabalin (PGB), 150 mg/day, and PGB, 600 mg/day, as an add-on treatment for patients with refractory partial seizures concurrently treated with one to three anticonvulsants (AEDs). Methods: An international (13 countri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e3dd7b9f4e399a11bc136e8426a149d
https://pubmed.ncbi.nlm.nih.gov/14692903